Singapore markets open in 2 hours 45 minutes

Teladoc Health, Inc. (TDOC)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
11.92+0.09 (+0.76%)
At close: 04:00PM EDT
11.95 +0.03 (+0.25%)
After hours: 06:11PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 2.01B
Enterprise value 2.50B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.75
Price/book (mrq)0.88
Enterprise value/revenue 0.95
Enterprise value/EBITDA 14.58

Trading information

Stock price history

Beta (5Y monthly) 0.97
52-week change 3-49.31%
S&P500 52-week change 329.31%
52-week high 330.41
52-week low 311.67
50-day moving average 313.80
200-day moving average 318.12

Share statistics

Avg vol (3-month) 35.02M
Avg vol (10-day) 35.2M
Shares outstanding 5169.59M
Implied shares outstanding 6169.59M
Float 8168.05M
% held by insiders 10.78%
% held by institutions 176.01%
Shares short (30 Apr 2024) 427.92M
Short ratio (30 Apr 2024) 45.26
Short % of float (30 Apr 2024) 421.45%
Short % of shares outstanding (30 Apr 2024) 416.46%
Shares short (prior month 28 Mar 2024) 420.88M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024


Profit margin -8.90%
Operating margin (ttm)-11.93%

Management effectiveness

Return on assets (ttm)-3.25%
Return on equity (ttm)-10.18%

Income statement

Revenue (ttm)2.62B
Revenue per share (ttm)15.80
Quarterly revenue growth (yoy)2.70%
Gross profit (ttm)N/A
Net income avi to common (ttm)-233.03M
Diluted EPS (ttm)-1.41
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.1B
Total cash per share (mrq)6.47
Total debt (mrq)1.59B
Total debt/equity (mrq)69.48%
Current ratio (mrq)3.82
Book value per share (mrq)13.52

Cash flow statement

Operating cash flow (ttm)345.78M
Levered free cash flow (ttm)306.86M